{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:48:46Z","timestamp":1761598126779,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:00:00Z","timestamp":1604793600000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.annder.2019.08.012","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T07:46:13Z","timestamp":1571125573000},"page":"725-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypersensibilit\u00e9 retard\u00e9e aux tatouages induite par un traitement combin\u00e9 anti-BRAF\/anti-MEK"],"prefix":"10.1016","volume":"146","author":[{"given":"E.","family":"Rohmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-N.","family":"Scrivener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cribier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lenormand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2019.08.012_bib0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.lpm.2016.02.016","article-title":"Cutaneous and systemic complications associated with tattooing","volume":"45","author":"Kluger","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.annder.2019.08.012_bib0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jdv.14181","article-title":"Recurrent tattoo reactions in a patient treated with BRAF and MEK inhibitors","volume":"31","author":"Reinhard","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.012_bib0135","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2006.01949.x","article-title":"Granulomatous tattoo reaction in a patient treated with etanercept","volume":"21","author":"Bachmeyer","year":"2007","journal-title":"J Eur Acad dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.012_bib0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/CMR.0000000000000486","article-title":"Tattoo-associated complications of metastatic melanoma treated with dabrafenib and trametinib","volume":"28","author":"Laske","year":"2018","journal-title":"Melanoma Res"},{"key":"10.1016\/j.annder.2019.08.012_bib0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.annder.2017.09.165","article-title":"R\u00e9actions granulomateuses sur tatouage sous anti-BRAF+anti-MEK r\u00e9v\u00e9latrices de fausses progressions","volume":"144","author":"Malissen","year":"2017","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.012_bib0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.annder.2018.03.165","article-title":"Traitements des patients atteints de melanoma de stade III inoperable ou de stade IV","volume":"145","author":"Guillot","year":"2018","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.012_bib0155","doi-asserted-by":"crossref","first-page":"450","DOI":"10.6004\/jnccn.2016.0051","article-title":"Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Coit","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.annder.2019.08.012_bib0160","first-page":"86","article-title":"Sarcoidosis on tattoo","volume":"30","author":"Kluger","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.annder.2019.08.012_bib0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000468536","article-title":"Cutaneous Complications related to tattoos: 31\u00a0cases from Finland","volume":"233","author":"Kluger","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2019.08.012_bib0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.annder.2010.08.019","article-title":"Les tatouages\u00a0: histoire naturelle et histopathologie des r\u00e9actions cutan\u00e9es","volume":"138","author":"Kluger","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.012_bib0175","series-title":"Dermatologie et infections sexuellement transmissibles","first-page":"446","author":"Saurat","year":"2017"},{"key":"10.1016\/j.annder.2019.08.012_bib0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000453379","article-title":"Atlas of illustrative cases of tattoo complications","volume":"52","author":"Serup","year":"2017","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.annder.2019.08.012_bib0185","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.16040","article-title":"Image Gallery: hyperkeratotic hypersensitivity reaction to red pigment tattoo","volume":"177","author":"Van Der Bent","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2019.08.012_bib0190","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.annder.2016.03.023","article-title":"R\u00e9actions dites allergiques aux tatouages\u00a0: prise en charge et algorithme th\u00e9rapeutique","volume":"143","author":"Kluger","year":"2016","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.08.012_bib0195","first-page":"669","article-title":"Cutaneous intolerance to tattoos in a patient with human immunodeficiency virus: a manifestation of the immune restoration syndrome","volume":"137","author":"Silvestre","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2019.08.012_bib0200","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1074-7613(00)80382-9","article-title":"The influence of the MAPK pathway on T cell lineage commitment","volume":"7","author":"Sharp","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.annder.2019.08.012_bib0205","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/bjc.2014.139","article-title":"Mechanism and consequences of RAF kinase activation by small-molecule inhibitors","volume":"111","author":"Holderfield","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annder.2019.08.012_bib0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/scitranslmed.aaa4691","article-title":"Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma","volume":"7","author":"Hu-Lieskovan","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.annder.2019.08.012_bib0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2018.08.019","article-title":"Immunomodulatory effects of BRAF and MEK Inhibitors: implications for Melanoma therapy","volume":"136","author":"Kuske","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.annder.2019.08.012_bib0220","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/ijc.28168","article-title":"Vemurafenib reverses immunosuppression by myeloid derived suppressor cells","volume":"133","author":"Schilling","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.annder.2019.08.012_bib0225","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1158\/1535-7163.MCT-14-0290","article-title":"Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma","volume":"13","author":"Ilieva","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.annder.2019.08.012_bib0230","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jamadermatol.2013.7919","article-title":"Cutaneous granulomatous eruption and successful response to petent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma","volume":"150","author":"Park","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2019.08.012_bib0235","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/CMR.0000000000000186","article-title":"Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib","volume":"25","author":"Jansen","year":"2015","journal-title":"Melanoma Res"},{"key":"10.1016\/j.annder.2019.08.012_bib0120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000439400","article-title":"Sarcoidosis in patients treated with vemurafenib for metastatic melanoma: a paradoxical autoimmune activation","volume":"231","author":"Lheure","year":"2015","journal-title":"Dermatology"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381930290X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381930290X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:07:31Z","timestamp":1758971251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S015196381930290X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S015196381930290X"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2019.08.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypersensibilit\u00e9 retard\u00e9e aux tatouages induite par un traitement combin\u00e9 anti-BRAF\/anti-MEK","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2019.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}